Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.
Pace
Andrea
A
Bove
Loredana
L
Jandolo
Bruno
B
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors; D002945:Cisplatin / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008870:Microtubules / Q000187:drug effects / Q000473:pathology; D009046:Motor Neurons / Q000187:drug effects / Q000378:metabolism; D009475:Neurons, Afferent / Q000187:drug effects / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017239:Paclitaxel / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D010525:Peripheral Nerves / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D015203:Reproducibility of Results; D014810:Vitamin E / Q000494:pharmacology / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D018696:Neuroprotective Agents; D014810:Vitamin E; D017239:Paclitaxel; D002945:Cisplatin